Ubs Group Ag Neurocrine Biosciences Inc Put Options Transaction History

Ubs Group Ag

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $1.07 Million - $1.4 Million	-14,800 Reduced 17.05%	72,000 $6.75 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $6.6 Million - $8.8 Million	82,800 Added 2070.0%	86,800 $7.39 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $344,720 - $396,120	4,000 New	4,000 $384,000

629

94.2M

692K

406K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.